Cardiac ArrhythmiaNCT06490432
Pattern of Cardiac Arrhythmia in Patients With MASLD
An observational study of Cardiac Arrhythmia and Metabolic Dysfunction Associated Steatotic Liver Disease, run by Sohag University at 1 site in Egypt.
Trial summary
Study the relationship between patients with MASLD and cardiac arrhythmia that could be occur in thos patients Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cardiac Arrhythmia, Metabolic Dysfunction Associated Steatotic Liver Disease
- What is being tested?
- Transient elastography
- Type of treatment
- Medical device
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 26 Jul 2024to 20 Oct 2025
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Study relationship between patients with metabolic dysfunction -assocatied steatotic liver disease and cardiac arrhythmia in those patients
Who may be able to join
- patients aged 18years or older Patients with metabolic dysfunction -assocatied steatotic liver disease
Who cannot join
- RHD Structural heart diseases Liver diseases other than MASLD
Trial locations and contacts
1 site in 1 country.
Usama Mohamed Abdalaal, Professor contact
Egypt1 site, 1 recruiting
- Recruiting
Sohag University Hospital
Sohag, So
Magdy M Amin, Professor
About this study
Official title: Pattern of Cardiac Arrhythmia in Patients With Metabolic Dysfunction -Assocatied Steatotic Liver Disease in Sohag University Hospital.
Study the relationship between patients with MASLD and cardiac arrhythmia that could be occur in thos patients
Read the detailed description
Study the cardiac arrhythmia that could be occur in patients suffering form metabolic dysfunction -assocatied steatotic liver disease and risk factors of them
- Being tested
- Transient elastography
- Medical subject headings
- Arrhythmias, Cardiac
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transient elastographyDevice
Also called Echocardiograpy, ECG
Device that measures stiffness of liver tissue
What is being measured
The primary outcome is the main question the study is designed to answer.
Cardiac arrhythmia and MASLD patients
Study metabolic dysfunction -assocatied steatotic liver disease
Measured: 1 year
Cardiac arrhythmia
Study pattern of cardiac arrhythmia
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2024
- Study start26 Jul 2024
- Primary completion1 Jul 2025 (estimated)
- Study completion20 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiac ArrhythmiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Asmaa Rashwan Ahmed, Sohag University
- Investigators
- Mohamed Ahmed Mostafa, Lecturer, Study director, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06490432
- Sponsor's protocol ID
- Soh-Med-24-06-04MS
- Status last verified
- Aug 2024
- First submitted
- 30 Jun 2024
- Last updated
- 7 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH, Lee H, Kim SU. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
PubMed 37907259